Bronnen
Bronnen per onderwerp
Alle cijfers op deze site zijn ontleend aan peer-reviewed onderzoek, officiële richtlijnen of overheidsrapporten. Hieronder per dossier de complete lijst, met DOI waar beschikbaar.
Centrale referentiebronnen
statsforgender.org — internationaal cijferarchief, regelmatig bijgewerkt
segm.org — Society for Evidence-Based Gender Medicine
cass.independent-review.uk — Cass Review (UK, 2024)
University of York — 7 systematische reviews voor de Cass Review
- Vlot MC et al. Effect of pubertal suppression and cross-sex hormone therapy on bone mineral apparent density. Bone. 2017. doi:10.1016/j.bone.2016.11.008
- Klink D et al. Bone mass in young adulthood following GnRHa treatment and cross-sex hormone treatment. JCEM. 2015. doi:10.1210/jc.2014-2439
- Joseph T et al. Effect of GnRH analogue treatment on BMD in young adolescents with gender dysphoria. J Pediatr Endocrinol Metab. 2019. doi:10.1515/jpem-2019-0008
- Schagen SEE et al. Bone development in transgender adolescents treated with GnRHa and gender-affirming hormones. JCEM. 2020. doi:10.1210/clinem/dgaa604
- Navabi B et al. Pubertal suppression, bone mass, and body composition in youth with gender dysphoria. Pediatrics. 2021. doi:10.1542/peds.2020-039339
- Hough D et al. Reduction in long-term spatial memory persists after discontinuation of peripubertal GnRHa in sheep. Psychoneuroendocrinology. 2017. doi:10.1016/j.psyneuen.2017.01.009
- Schneider MA et al. Brain Maturation, Cognition and Voice Pattern in a Gender Dysphoria Case under Pubertal Suppression. Front Hum Neurosci. 2017. doi:10.3389/fnhum.2017.00528
- de Vries ALC et al. Puberty suppression in adolescents with gender identity disorder. Pediatrics. 2011. doi:10.1542/peds.2010-2197
- Brik T et al. Trajectories of adolescents treated with GnRH analogues for gender dysphoria. Arch Sex Behav. 2020. doi:10.1007/s10508-020-01660-8
- Carmichael P et al. Short-term outcomes of pubertal suppression in a UK cohort. PLOS ONE. 2021. doi:10.1371/journal.pone.0243894
- Getahun D et al. Cross-sex hormones and acute cardiovascular events in transgender persons. Ann Intern Med. 2018. doi:10.7326/M17-2785
- Nota NM et al. Occurrence of acute cardiovascular events in transgender individuals receiving hormone therapy. Circulation. 2019. doi:10.1161/CIRCULATIONAHA.118.038584
- Wiepjes CM et al. The Amsterdam Cohort of Gender Dysphoria Study (1972–2015). J Sex Med. 2018. doi:10.1016/j.jsxm.2018.01.016
- de Blok CJM et al. Breast cancer risk in transgender people receiving hormone treatment. BMJ. 2019. doi:10.1136/bmj.l1652
- Weill A et al. Use of high dose cyproterone acetate and risk of intracranial meningioma. BMJ. 2021. doi:10.1136/bmj.n37
- Madsen MC et al. Erythrocytosis in trans men using testosterone. J Sex Med. 2021. doi:10.1016/j.jsxm.2021.04.009
- Connelly PJ et al. Gender-affirming hormone therapy, vascular health and cardiovascular disease. Hypertension. 2019. doi:10.1161/HYPERTENSIONAHA.119.13080
- Grimstad F et al. New-onset abdominopelvic pain after initiation of testosterone therapy. J Endocr Soc. 2020. doi:10.1210/jendso/bvaa008
- Hembree WC et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons (Endocrine Society Guideline). JCEM. 2017. doi:10.1210/jc.2017-01658
- Cheng PJ et al. Fertility concerns of the transgender patient. Transl Androl Urol. 2019. doi:10.21037/tau.2019.05.09
- Al-Tamimi M et al. Surgical outcomes and complications of free-flap phalloplasty in transgender men. Eur Urol. 2019.
- Cuccolo NG et al. Mastectomy in transgender and cisgender patients. Ann Plast Surg. 2019.
- Olson-Kennedy J et al. Chest reconstruction and chest dysphoria in transmasculine minors. JAMA Pediatr. 2018. doi:10.1001/jamapediatrics.2017.5440
- Dreher PC et al. Complications of the neovagina in male-to-female transgender surgery. Clin Anat. 2018.
- Hontscharuk R et al. Penile inversion vaginoplasty outcomes. J Urol. 2021.
- Nikolavsky D et al. Urologic complications in transgender patients undergoing genital affirming surgery. J Urol. 2021.
- Heston AL et al. Phalloplasty: techniques and outcomes. Transl Androl Urol. 2019.
- Morrison SD et al. Phalloplasty: a review of techniques and outcomes. Plast Reconstr Surg. 2016.
- WPATH. Standards of Care, Version 8. 2022.
- Vandenbussche E. Detransition-related needs and support. J Homosex. 2022. doi:10.1080/00918369.2021.1919479
- Littman L. Individuals treated for gender dysphoria who detransitioned. Arch Sex Behav. 2021. doi:10.1007/s10508-021-02163-w
- Hall R et al. Access to care and frequency of detransition (UK NHS GIC). BMJ Mental Health. 2021. doi:10.1136/bmjment-2021-300031
- Boyd I et al. Care of transgender patients by general practitioners. Br J Gen Pract. 2022.
- Roberts CM et al. Continuation of gender-affirming hormones among transgender adolescents and adults. JCEM. 2022. doi:10.1210/clinem/dgac251
- Hisle-Gorman E et al. Mental healthcare utilization of transgender youth. J Sex Med. 2021. doi:10.1016/j.jsxm.2021.05.014
- Pazos Guerra M et al. Transsexuality: transitions, detransitions, and regrets in Spain. Andrology. 2024.
- Expósito-Campos P, Salaberria K. Systematic review/meta-analysis of detransition rates. 2024.
- Dhejne C et al. Long-term follow-up of transsexual persons undergoing sex reassignment surgery (Zweden). PLOS ONE. 2011. doi:10.1371/journal.pone.0016885
- Dhejne C et al. Applications for sex reassignment surgery in Sweden, 1960–2010. Arch Sex Behav. 2014. doi:10.1007/s10508-014-0300-8
- Bränström R, Pachankis JE. Reduction in mental health treatment utilization after gender-affirming surgeries (+ Correction 2020). Am J Psychiatry. 2019/2020. doi:10.1176/appi.ajp.2019.19010080
- Bustos VP et al. Regret after gender-affirmation surgery: meta-analysis. Plast Reconstr Surg Glob Open. 2021. doi:10.1097/GOX.0000000000003477
- Asscheman H et al. Mortality in transsexuals receiving cross-sex hormone treatment. Eur J Endocrinol. 2011.
- de Blok CJM et al. Mortality trends over five decades in adult transgender people. Lancet Diabetes Endocrinol. 2021.
- Erlangsen A et al. Transgender identity and suicide attempts/mortality in Denmark. JAMA. 2023. doi:10.1001/jama.2023.6322
- Jackson SS et al. Suicide mortality among transgender veterans. JAMA Netw Open. 2022.
- Cass H. Independent Review — Final Report (Appendix C). 2024.
- Arnoldussen M et al. Re-evaluation of the Dutch approach. Eur Child Adolesc Psychiatry. 2020.
- Socialstyrelsen. Utvecklingen av diagnosen könsdysfori. 2020.
- Kaltiala-Heino R et al. Two years of gender identity service for minors. Child Adolesc Psychiatry Ment Health. 2015.
- Respaut R, Terhune C. Reuters Investigates. Oktober 2022.
- Komodo Health analyse (geciteerd in Reuters 2022).
- Bauer G et al. Trends in prescription puberty blockers and hormones. JAMA Pediatr. 2023.
- Cass H. Final Report. 2024. cass.independent-review.uk
- SBU. Hormone treatment of children and adolescents with gender dysphoria. 2022.
- Socialstyrelsen. Kunskapsstöd. 2022.
- Karolinska University Hospital — policy statement. Mei 2021.
- COHERE Finland. Recommendation. Juni 2020. palveluvalikoima.fi
- HAS (France). Parcours de transition des personnes transgenres. 2022/2025.
- Académie Nationale de Médecine. Februari 2022.
- UKOM (Norway). 2023.
- Biggs M. The Dutch Protocol: Origins and Evidence. J Sex Marital Ther. 2023.
- NICE. Evidence reviews on GnRHa & CSH. 2020.